Investigating how fluid flow in the brain helps clear waste related to Alzheimer's disease
Novel tracers for in vivo studies of waste transport by fluid flows in the brain
This study is looking at how fluid movement in the brain helps clear away harmful substances like amyloid beta, which are linked to Alzheimer's disease, and it aims to find new ways to keep the brain healthy for people affected by this condition.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cornell University NIH-funded |
| Lab location | 1 site (Ithaca, United States) |
| Project ID | NIH-10732612 on NIH RePORTER |
What this research studies
This research explores the role of interstitial fluid motion in the brain, specifically how it may aid in the clearance of amyloid beta and other waste products that could contribute to Alzheimer's disease. By using novel genetically engineered tracers, the study aims to better understand the pathways through which these substances are transported out of the brain. The research will address existing gaps in knowledge regarding the outflow mechanisms of fluid and waste, which are crucial for maintaining brain health. Patients may benefit from insights gained that could lead to new therapeutic strategies for Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance waste clearance in the brain, potentially slowing the progression of Alzheimer's disease.
How similar studies have performed: While the mechanisms of waste clearance in the brain are being actively studied, the use of genetically engineered tracers for this specific purpose is a novel approach.
Where this research is happening
Ithaca, United States
- Cornell University — Ithaca, United States (Active)
Researchers
- Principal investigator: Nishimura, Nozomi — Cornell University
- Study coordinator: Nishimura, Nozomi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.